ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Cash Interest Paid
ADC Therapeutics SA
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Cash Interest Paid
$21.4m
|
CAGR 3-Years
139%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Cash Interest Paid
CHf176k
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash Interest Paid
CHf9.8m
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash Interest Paid
CHf19k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Cash Interest Paid?
Cash Interest Paid
21.4m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Cash Interest Paid amounts to 21.4m USD.
What is ADC Therapeutics SA's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
139%
Over the last year, the Cash Interest Paid growth was 0%. The average annual Cash Interest Paid growth rates for ADC Therapeutics SA have been 139% over the past three years .